Welcome to our dedicated page for Dana SEC filings (Ticker: DAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking powertrain innovation is exciting—decoding the disclosures behind it is not. Dana Inc’s SEC reports weave together axle specifications, electric-drive rollouts, warranty reserves, and OEM contract details that can easily span 300 pages. If you have ever searched for Dana Inc insider trading Form 4 transactions or wondered where the latest Dana Inc quarterly earnings report 10-Q filing hides segment margins, you already know the challenge.
Stock Titan solves it. Our AI reads every disclosure the moment it hits EDGAR, delivering Dana Inc Form 4 insider transactions real-time alerts, concise breakdowns of cash-flow swings, and line-by-line context so you leave with Dana Inc SEC filings explained simply. Whether you need a fast Dana Inc earnings report filing analysis, help understanding Dana Inc SEC documents with AI, or a red-flag summary of fresh 8-Ks, the platform surfaces what matters and trims the rest.
Dig deeper into electrification capex inside the Dana Inc annual report 10-K simplified; compare light-vehicle profitability across quarters in one click; or monitor Dana Inc executive stock transactions Form 4 before new drivetrain awards. Our coverage includes the Dana Inc proxy statement executive compensation to reveal incentive targets and the Dana Inc 8-K material events explained feed for contract wins or plant realignments. Real-time updates, AI-powered summaries, and expert commentary—everything you need to turn complex mobility disclosures into clear, actionable insight.
Quantum Corp. (QMCO) received a Nasdaq deficiency notice on 17 Jul 2025 for not filing its Form 10-K for FY-end 31 Mar 2025 within the required period, violating Listing Rule 5250(c)(1).
The company had already filed a Form 12b-25 on 30 Jun 2025, citing the need for extra time to review revenue-recognition accounting, including standalone selling-price analyses for certain contracts. Management says it is “working diligently” to complete the review and submit the annual report within Nasdaq’s cure timeline.
Immediate impact: QMCO shares remain listed and continue trading on the Nasdaq Global Market while the company remedies the filing lapse. Continued listing is subject to satisfying other Nasdaq requirements.
On 23 Jul 2025 QMCO issued a press release (Exhibit 99.1) disclosing the notice. No financial results, guidance, or other material transactions were included in the 8-K.